This page shows the latest Highly Specialised Technology news and features for those working in and with pharma, biotech and healthcare.
The positive recommendation of Brineura was agreed by NICE’s Highly Specialised Technology committee. ... Meindert Boysen, director of the Centre for Health Technology Evaluation at NICE.
a prevalence to go through NICE's highly specialised technology (HST) route, which is reserved for the rarest orphan and ultra-orphan treatments. ... Patient groups say the health economics of a rare disease like SMA make it highly unlikely to be passed
The decision, which was published under NICE’s Highly Specialised Technology (HST) committee, marks the end of a year-long negotiation between BioMarin and NHS England. ... Once these elements are excluded, the cost-effectiveness estimates for
NICE has a Highly Specialised Technology (HST) appraisal, which has seen a number of innovative pricing and reimbursement deals done with companies to bring orphan and ultra-orphan drugs to NHS ... patients. However many rare diseases do not qualify for
The fee for single technology appraisals (STAs) and highly specialised technology appraisals (HTAs) will be £126, 000 ($158, 500, 140, 400).
NICE is proposing that bigger companies pay £126, 000 ($160, 000) for a single technology appraisal or a highly specialised technology appraisal (for rare disease drugs), or £94, 500 for smaller ... Industry association the ABPI hasn’t yet responded
More from news
Approximately 1 fully matching, plus 12 partially matching documents found.
The 2019 Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) included a commitment from NICE to scope and initiate a review of the methods for its Technology Appraisal Programme (TAP) ... A broad range of technologies. NICE has said that the
The row boiled over into accusations being traded publicly – Vertex calling the health service budget holder’s stance ‘outrageous’ last summer and NHS England’s head of specialised medicines commissioning John ... The STA system doesn’t
NICE, which has its own Highly Specialised Technology (HST) assessment process, has come under fire for the change in April 2017 to the way it assesses therapies to treat the rarest
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...